Quoin Pharmaceuticals Statistics
Total Valuation
QNRX has a market cap or net worth of $3.86 million. The enterprise value is -$7.27 million.
| Market Cap | 3.86M |
| Enterprise Value | -7.27M |
Important Dates
The next estimated earnings date is Thursday, May 8, 2025, before market open.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
QNRX has 588,166 shares outstanding. The number of shares has increased by 420.43% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 588,166 |
| Shares Change (YoY) | +420.43% |
| Shares Change (QoQ) | +29.54% |
| Owned by Insiders (%) | 7.08% |
| Owned by Institutions (%) | 9.56% |
| Float | 546,540 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.18 |
| P/TBV Ratio | 0.44 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.57, with a Debt / Equity ratio of 0.32.
| Current Ratio | 3.57 |
| Quick Ratio | 3.36 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -120.55% and return on invested capital (ROIC) is -55.88%.
| Return on Equity (ROE) | -120.55% |
| Return on Assets (ROA) | -42.72% |
| Return on Invested Capital (ROIC) | -55.88% |
| Return on Capital Employed (ROCE) | -82.65% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.79M |
| Employee Count | 5 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -72.51% in the last 52 weeks. The beta is 1.61, so QNRX's price volatility has been higher than the market average.
| Beta (5Y) | 1.61 |
| 52-Week Price Change | -72.51% |
| 50-Day Moving Average | 9.35 |
| 200-Day Moving Average | 18.15 |
| Relative Strength Index (RSI) | 42.08 |
| Average Volume (20 Days) | 353,648 |
Short Selling Information
| Short Interest | 174,011 |
| Short Previous Month | 868,761 |
| Short % of Shares Out | 29.59% |
| Short % of Float | 31.84% |
| Short Ratio (days to cover) | 0.23 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -9.53M |
| Pretax Income | -8.28M |
| Net Income | -8.96M |
| EBITDA | -9.43M |
| EBIT | -9.53M |
| Earnings Per Share (EPS) | -$66.90 |
Balance Sheet
The company has $14.06 million in cash and $2.92 million in debt, giving a net cash position of $11.13 million or $18.93 per share.
| Cash & Cash Equivalents | 14.06M |
| Total Debt | 2.92M |
| Net Cash | 11.13M |
| Net Cash Per Share | $18.93 |
| Equity (Book Value) | 9.20M |
| Book Value Per Share | 36.00 |
| Working Capital | 10.75M |
Cash Flow
| Operating Cash Flow | -7.86M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
QNRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -420.43% |
| Shareholder Yield | -420.43% |
| Earnings Yield | -232.29% |
| FCF Yield | n/a |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on April 9, 2025. It was a reverse split with a ratio of 0.0285714:1.
| Last Split Date | Apr 9, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.0285714:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |